Remove 2021 Remove Hospitals Remove Labelling
article thumbnail

Pharmacist-led inpatient penicillin allergy delabelling: case study insights

Hospital Pharmacy Europe

Penicillin allergies are frequently mislabelled, resulting in unnecessary broad-spectrum antibiotic use and extended hospital stays. At London North West University Healthcare NHS Trust, a team has implemented a pharmacist-led inpatient delabelling service that safely removes inaccurate allergy labels through direct oral challenges.

article thumbnail

From ward manipulations to 3D printing: shaping the future of personalised medication

Hospital Pharmacy Europe

However, in many clinical settings, including hospital wards, a prescribed tablet strength may not be available, or a patient might have difficulty swallowing solid oral dosage forms. In 2017, it set an ambitious goal to reduce severe, avoidable medication errors by 50% within five years.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How and why pharmacists should get involved in clinical research

Hospital Pharmacy Europe

For pharmacists with the will, time and support to get involved in clinical research, the benefits are many not only for them, but also for their patients, teams and hospitals. With a workforce under pressure, getting involved in clinical trials and pilot research projects might be the last thing on hospital pharmacists minds.

article thumbnail

A pharmacist’s take on actions from the child asthma and anaphylaxis deaths report

Hospital Pharmacy Europe

Key findings in this review emphasised that most of these children and young people died before reaching the hospital, with 46% receiving inadequate asthma care. Some deaths occurred due to cardiac arrest, predominantly outside of hospitals, with 29 children (58%) having unsuccessful cardiopulmonary resuscitation. Accessed March 2025].

article thumbnail

Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike

Pharmacy Times

Difficile COPD COVID-19 Cardiovascular Health Cervical Cancer Cholangiocarcinoma Cholesterol Chronic Kidney Disease Chronic Lymphocytic Leukemia Classical Hematology Colorectal Cancer Continuous Glucose Monitoring Cough and Cold Depression Dermatology Diabetes Digestive Health Dry Eye Disease Epilepsy Eye Care Flu Future of Pharmacy Gastrointestinal (..)

article thumbnail

Ropeginterferon Alfa 2b Is Well-Tolerated, Efficacious in Treatment of Prefibrotic Myelofibrosis

Pharmacy Times

It was originally approved in 2021 for the treatment of polycythemia vera and the manufacturer, as of January 2025, is seeking to expand the agent’s indication to the treatment of essential thrombocytopenia based on data from the SURPASS-ET trial (NCT04285086). November 12, 2021. Accessed June 20, 2025. Updated November 30, 2023.

article thumbnail

Ascendis Pharma’s Skytrofa gains FDA approval for growth hormone deficiency

Pharmaceutical Technology

Find out more Skytrofa was previously approved by the FDA in 2021 to treat children and paediatric patients aged one year or above weighing at least 11.5kg and are experiencing growth failure due to inadequate secretion of endogenous growth hormone (GH). GlobalData Strategic Intelligence US Tariffs are shifting - will you react or anticipate?

FDA